https://medicine.ouhsc.edu/academic-departments Parent Page: Academic Departments id: 22888 Active Page: Surgery Faculty id:26604

Faculty

Surgery

Barish H. Edil, MD, FACS

Professor & Chair Department of Surgery University of Oklahoma

John A. Schilling Endowed Chair Surgeon-in-Chief of OU Health System


Barish Edil, MD, FACS, is a Professor and Chair of Surgery at the University of Oklahoma. He is board certified by the American Board of Surgery and works within the Gastrointestinal Cancers Clinic at Stephenson Cancer Center. Dr. Edil also serves on the Operations Committee and the OU Physicians Council at the University of Oklahoma Health Sciences Center.

Prior to joining the University of Oklahoma, Dr. Edil was the Chief of Surgical Oncology at the University of Colorado in Aurora, CO. He was also a faculty member at the Johns Hopkins University School of Medicine, where he served as the Director and Coordinator of the Physician’s Assistant Surgery Residency and the Medical Student Surgical Oncology Rotations.

Dr. Edil completed medical school at the University of Wisconsin School of Medicine. He then attended the University of Oklahoma Health Sciences Center to complete a General Surgery Internship, a Surgical Oncology Research Fellowship and a General Surgery Residency. He also completed the Assistant Chief of Service in Clinical Fellowship at the Johns Hopkins University School of Medicine.


Academic Section(s):

Surgical Oncology


Education:

Medical School: University of Wisconsin School of Medicine/Madison


Board Certification(s):

American Board of Surgery


Fellowship:

Residency: General Surgery, University of Oklahoma/Oklahoma City

Fellowships: 

  • Research Fellowship, University of Oklahoma/Oklahoma City
  • Surgical Oncology, The Johns Hopkins School of Medicine/Baltimore


Clinical/Research Interests:

Clinical Focus: Hepato-Pancreato-Biliary Surgery, Surgical Oncology

Clinical Interests: Pancreas, Bile Duct, Liver, Stomach, Adrenal, Sarcoma, Cancer Surgery

​Research Interests: ​Vaccine Therapy for Pancreatic Cancer Patients